The problem right now is nothing is acceptable for the shareholder and it has been that way for weeks / months. Everyone has been underwater for quite a while and even selling hasn't been a real option because of losing quite a bit of money or all of their money. Dropping to .10 is totally unacceptable.

Generex Management needs to work all of this out hopefully and come through with their products that have been proven and not follow down a rabbit hole.

They have again, the products, the science, the team in place. They just need to focus on what they do best and stick to it. The deals they have hopefully will work themselves out. The listing hopefully will happen and NGIO will help everyone and in the meantime, they need to get Excellegan in the marketplace to the VA and hospitals and finally overseas. They need to work on their cancer drug to get that going and get their virus platform up. But they need to do it in steps.